Company Overview and News

 
Hotel sector seen as red hot for growth

2018-03-16 theage.com.au
The hotel sector is one of the most active for investors with the InterContinental Hotels Group snapping up a controlling stake in the luxe Regents Hotel and Resorts operations.
Upvote Downvote

 
Hotel sector seen as red hot for growth

2018-03-16 smh.com.au
The hotel sector is one of the most active for investors with the InterContinental Hotels Group snapping up a controlling stake in the luxe Regents Hotel and Resorts operations.
Upvote Downvote

 
Social Services staff tell bosses something stinks at new Tuggeranong offices

2018-02-16 smh.com.au
Public servants feeling sick and complaining of sore eyes and the smell of poo at the Department of Social Services' new Tuggeranong offices have learnt that grey water vapours have entered their air conditioning.
Upvote Downvote

 
A-REITs to underperform against equities: analysts

2018-02-06 theage.com.au
Australia’s listed real estate trusts are likely to underperform equities again this year as rising bond yields cause volatility in both sectors, analysts say.
Upvote Downvote

 
A-REITs to underperform against equities: analysts

2018-02-06 smh.com.au
Australia’s listed real estate trusts are likely to underperform equities again this year as rising bond yields cause volatility in both sectors, analysts say.
Upvote Downvote

 
Calvary Wakefield private hospital and medical clinic sells for $50 million

2017-12-14 perthnow.com.au
A WELL known private Adelaide hospital has changed hands today for a price 20 per cent higher than its book value.
Upvote Downvote

 
UPDATE 1-Cromwell European REIT debuts at offer price in Singapore

2017-11-30 reuters
* REIT comprises office, logistics, retail assets in Europe (Adds data on exchange listings, details of Cromwell IPO)
Upvote Downvote

 
Sydney, Melbourne record highest rent growth globally

2017-11-28 theage.com.au
Demand for office space has propelled Sydney and Melbourne to record the highest annual rental growth in the world, according to the latest JLL Global Office index.
Upvote Downvote

 
Sydney, Melbourne record highest rent growth globally

2017-11-28 smh.com.au
Demand for office space has propelled Sydney and Melbourne to record the highest annual rental growth in the world, according to the latest JLL Global Office index.
Upvote Downvote

 
1% Luck, 99% Hard Work for Singapore's SGX - Bloomberg

2017-09-27 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Department of Social Services moves to new $172 million office

2017-09-26 smh.com.au
The Department of Social Services' new national headquarters at the corner of Athllon Drive and Soward Way will be home to 2,500 staff.
Upvote Downvote

 
UPDATE 1-Australia's Cromwell seeks up to $1.1 bln with Singapore REIT offering -IFR

2017-09-18 reuters
* IPO to be priced Sept. 21, debut Sept. 28 (Adds details on cornerstone investors, pricing and debut dates)
Upvote Downvote

 
ASX falls 1.7pc on Friday but finishes week in the black

2017-06-30 theage.com.au
Shares lost $28 billion in value on Friday and the ASX suffered its worst session since November of last year as investors were swept up in a global sell-off.
Upvote Downvote

 
ASX falls 1.7pc on Friday but finishes week in the black

2017-06-30 smh.com.au
Shares lost $28 billion in value on Friday and the ASX suffered its worst session since November of last year as investors were swept up in a global sell-off.
Upvote Downvote

 
Growthpoint, Cromwell increase tenant lists

2017-04-11 theage.com.au
The stronger leasing markets have led to an increase in landlords Growthpoint and Cromwell Corp's tenants profiles across Melbourne and Sydney.
Upvote Downvote

Related Articles

GNCA: Genocea Biosciences Analysis and Research Report

2018-04-25 - Asif

Overview Genocea Biosciences is a biopharmaceutical company that discovers and develops novel cancer vaccines. The company use its proprietary discovery platform, ATLAS, to recall a patient’s pre-existing CD4+ and CD8+ T cell immune responses to their tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. The company believe that using ATLAS to identify antigens for inclusion in cancer vaccines could lead to more immunogenic and efficacious cancer vaccines. In September 2017, the company announced a strategic shift to immuno-oncology and a focus on the development of neoantigen cancer vaccines. Currently, all of its research programs and product candidates in active development are at the preclinical stage. The company's most advanced program is its preclinical immuno-oncology program, GEN-009, a neoantigen cancer vaccine. The GEN-009 program uses ATLAS to identify patient neoantigens, or newly formed anti...

AMZN: Amazon.com, Inc Analysis and Research Report

2018-04-25 - Asif

Overview Amazon.com opened its virtual doors on the World Wide Web in July 1995. The company seek to be Earth’s most customer-centric company. Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. In each of its segments, the company serve its primary customer sets, consisting of consumers, sellers, developers, enterprises, and content creators. In addition, the company provide services, such as advertising services and co-branded credit card agreements. Amazon has organized its operations into three segments: North America, International, and Amazon Web Services (“AWS”). These segments reflect the way the Company evaluates its business performance and manages its operations. Additional information on its operating segments and its net sales is contained in Item 8 of Part II, “Financial Statements and Supplementary Data—Note 11—Segment Information.” The compan...

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...